Shopping Cart 0
Cart Subtotal
USD 0

United States CSF Management Market Outlook to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 9990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 14985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

United States CSF Management Market Outlook to 2023

Summary

GlobalData's new report, "United States CSF Management Market Outlook to 2023", provides key market data on the United States CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments-Hydrocephalus Shunts and Dura Substitutes.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for CSF Management market segments-Hydrocephalus Shunts and Dura Substitutes.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the United States CSF Management market.

Key players covered include Integra LifeSciences Holdings Corp, Medtronic plc, DePuy Synthes Inc and Others.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 CSF Management Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 CSF Management Market, United States 7

3.1 CSF Management Market, United States, Revenue ($m), 2009-2016 7

3.2 CSF Management Market, United States, Revenue ($m), 2016-2023 9

3.3 CSF Management Market, United States, Volume (Units), 2009-2016 11

3.4 CSF Management Market, United States, Volume (Units), 2016-2023 13

3.5 CSF Management Market, United States, Average Price ($), 2009-2023 15

3.6 CSF Management Market, United States, Distribution Share by Revenue ($m), 2015-2016 16

3.7 CSF Management Market, United States, Company Share by Revenue ($m), 2016 17

4 Overview of Key Companies in United States, CSF Management Market 18

4.1 Integra LifeSciences Holdings Corp 18

4.1.1 Company Overview 18

4.2 Medtronic Plc 18

4.2.1 Company Overview 18

4.3 DePuy Synthes Inc 18

4.3.1 Company Overview 18

4.4 B. Braun Melsungen AG 18

4.4.1 Company Overview 18

5 CSF Management Market Pipeline Products 19

6 Financial Deals Landscape 20

6.1 Asset Transactions 20

6.1.1 Integra LifeSciences Plans to Acquire Neurosurgery Business of Codman Neuro for USD1 Billion 20

6.2 Venture Financing 22

6.2.1 Arkis BioSciences Raises USD3.4 Million in Series A Venture Financing 22

7 Recent Developments 23

7.1 Corporate Communications 23

7.1.1 Dec 05, 2016: Integra LifeSciences announces management changes 23

7.1.2 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 23

7.2 Financial Announcements 24

7.2.1 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 24

7.2.2 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 25

7.2.3 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 26

7.2.4 Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results 26

7.3 Legal And Regulatory 27

7.3.1 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 27

7.4 Other Significant Developments 28

7.4.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 28

8 Appendix 29

8.1 Research Methodology 30

8.1.1 Coverage 30

8.1.2 Secondary Research 30

8.1.3 Primary Research 31

8.1.4 Company Share Analysis 31

8.1.5 Distribution Share Analysis 31

8.1.6 Benchmarking 32

8.2 GlobalData Consulting 32

8.3 Contact Us 33

8.4 Disclaimer 33


List Of Figure

1.2 List of Figures

Figure 1: CSF Management Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 7

Figure 2: CSF Management Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 9

Figure 3: CSF Management Market, United States, Volume (Units), Historic, 2009-2016 11

Figure 4: CSF Management Market, United States, Volume (Units), Forecast, 2016-2023 13

Figure 5: CSF Management Market, United States, Company Share (%) 2016 17


List Of Table

1.1 List of Tables

Table 1: CSF Management Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 8

Table 2: CSF Management Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 10

Table 3: CSF Management Market, United States, Volume (Units), Historic, 2009-2016 12

Table 4: CSF Management Market, United States, Volume (Units), Forecast, 2016-2023 14

Table 5: CSF Management Market, United States, Average Price ($), Historic, 2009-2016 15

Table 6: CSF Management Market, United States, Average Price ($), Forecast, 2016-2023 15

Table 7: CSF Management Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 16

Table 8: CSF Management Market, United States, Company Share by Revenue ($m), USD Constant, 2016 17

Table 9: CSF Management Market Pipeline Products 19

Table 10: Integra LifeSciences Plans to Acquire Neurosurgery Business of Codman Neuro for USD1 Billion 20

Table 11: Arkis BioSciences Raises USD3.4 Million in Series A Venture Financing 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Neurology Devices, CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products, Radiosurgery, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, St. Jude Medical LLC, Boston Scientific Corp, DePuy Synthes Inc, LivaNova PLC, Stryker Corporation, Natus Medical Incorporated, Terumo Corp, Elekta AB, Integra LifeSciences Holdings Corp, B. Braun Melsungen AG, Nihon Kohden Corp, Accuray Inc, KARL STORZ GmbH & Co KG, MIZUHO Co., Ltd., W. L. Gore & Associates Inc, Sophysa SA


Companies

Integra LifeSciences Holdings Corp, Medtronic Plc, DePuy Synthes Inc, B. Braun Melsungen AG

United States CSF Management Market Outlook to 2023

Summary

GlobalData's new report, "United States CSF Management Market Outlook to 2023", provides key market data on the United States CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments-Hydrocephalus Shunts and Dura Substitutes.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for CSF Management market segments-Hydrocephalus Shunts and Dura Substitutes.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the United States CSF Management market.

Key players covered include Integra LifeSciences Holdings Corp, Medtronic plc, DePuy Synthes Inc and Others.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 CSF Management Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 CSF Management Market, United States 7

3.1 CSF Management Market, United States, Revenue ($m), 2009-2016 7

3.2 CSF Management Market, United States, Revenue ($m), 2016-2023 9

3.3 CSF Management Market, United States, Volume (Units), 2009-2016 11

3.4 CSF Management Market, United States, Volume (Units), 2016-2023 13

3.5 CSF Management Market, United States, Average Price ($), 2009-2023 15

3.6 CSF Management Market, United States, Distribution Share by Revenue ($m), 2015-2016 16

3.7 CSF Management Market, United States, Company Share by Revenue ($m), 2016 17

4 Overview of Key Companies in United States, CSF Management Market 18

4.1 Integra LifeSciences Holdings Corp 18

4.1.1 Company Overview 18

4.2 Medtronic Plc 18

4.2.1 Company Overview 18

4.3 DePuy Synthes Inc 18

4.3.1 Company Overview 18

4.4 B. Braun Melsungen AG 18

4.4.1 Company Overview 18

5 CSF Management Market Pipeline Products 19

6 Financial Deals Landscape 20

6.1 Asset Transactions 20

6.1.1 Integra LifeSciences Plans to Acquire Neurosurgery Business of Codman Neuro for USD1 Billion 20

6.2 Venture Financing 22

6.2.1 Arkis BioSciences Raises USD3.4 Million in Series A Venture Financing 22

7 Recent Developments 23

7.1 Corporate Communications 23

7.1.1 Dec 05, 2016: Integra LifeSciences announces management changes 23

7.1.2 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 23

7.2 Financial Announcements 24

7.2.1 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 24

7.2.2 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 25

7.2.3 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 26

7.2.4 Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results 26

7.3 Legal And Regulatory 27

7.3.1 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 27

7.4 Other Significant Developments 28

7.4.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 28

8 Appendix 29

8.1 Research Methodology 30

8.1.1 Coverage 30

8.1.2 Secondary Research 30

8.1.3 Primary Research 31

8.1.4 Company Share Analysis 31

8.1.5 Distribution Share Analysis 31

8.1.6 Benchmarking 32

8.2 GlobalData Consulting 32

8.3 Contact Us 33

8.4 Disclaimer 33


List Of Figure

1.2 List of Figures

Figure 1: CSF Management Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 7

Figure 2: CSF Management Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 9

Figure 3: CSF Management Market, United States, Volume (Units), Historic, 2009-2016 11

Figure 4: CSF Management Market, United States, Volume (Units), Forecast, 2016-2023 13

Figure 5: CSF Management Market, United States, Company Share (%) 2016 17


List Of Table

1.1 List of Tables

Table 1: CSF Management Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 8

Table 2: CSF Management Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 10

Table 3: CSF Management Market, United States, Volume (Units), Historic, 2009-2016 12

Table 4: CSF Management Market, United States, Volume (Units), Forecast, 2016-2023 14

Table 5: CSF Management Market, United States, Average Price ($), Historic, 2009-2016 15

Table 6: CSF Management Market, United States, Average Price ($), Forecast, 2016-2023 15

Table 7: CSF Management Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 16

Table 8: CSF Management Market, United States, Company Share by Revenue ($m), USD Constant, 2016 17

Table 9: CSF Management Market Pipeline Products 19

Table 10: Integra LifeSciences Plans to Acquire Neurosurgery Business of Codman Neuro for USD1 Billion 20

Table 11: Arkis BioSciences Raises USD3.4 Million in Series A Venture Financing 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Neurology Devices, CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products, Radiosurgery, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, St. Jude Medical LLC, Boston Scientific Corp, DePuy Synthes Inc, LivaNova PLC, Stryker Corporation, Natus Medical Incorporated, Terumo Corp, Elekta AB, Integra LifeSciences Holdings Corp, B. Braun Melsungen AG, Nihon Kohden Corp, Accuray Inc, KARL STORZ GmbH & Co KG, MIZUHO Co., Ltd., W. L. Gore & Associates Inc, Sophysa SA


Companies

Integra LifeSciences Holdings Corp, Medtronic Plc, DePuy Synthes Inc, B. Braun Melsungen AG